Eastbourne Capital Management - Investor Profile


Primary Address:

Investor Information:

1101 Fifth AvenueTotal AUM ($MM):434
Suite 370Equity AUM ($MM):NA
San Rafael, CA 94901Investment Style:Value
United StatesOrientation:Shareholder Activist
Phone: 415-448-1200 Investor Type:Hedge Fund Manager
Fax: 415-448-1201

Institutional Investor Background


Eastbourne Capital Management is a hedge fund manager that was formed in 1999 when Rick Barry and his investment team spun off from Robertson Stephens Investment Management. The portfolio management team, which is led by Mr. Barry, started managing the firm's hedge funds in 1995 while at Robertson Stephens. Prior to Robertson Stephens, from 1992-1995, Mr. Barry served as an analyst for Banyan Securities, where he provided in-depth equity research primarily for hedge funds. Prior to that, he was a portfolio manager at Regal Asset Management and an analyst with the Feshbach Brothers in Dallas. In addition to Mr. Barry, the Eastbourne investment team includes two analysts and three traders. Investments by the principals and employees of the firm represent more than 10% of Eastbourne's total assets. Eastbourne's portfolio management services span various market capitalizations, liquidity, industries, valuations and investment structures. The firm also manages the Black Bear hedge funds and the Black Bear family of trust funds.

Founders and Key Executives of Eastbourne Capital Management: Rick Barry

Entities related to Eastbourne Capital Management: Black Bear Hedge Funds; Robertson Stephens*

*Denotes that the person or entity is no longer related to the firm. **If you would like to submit investor updates, please click here



See Investor Roadshow Profile for Comprehensive Investment Strategy and Complete Holdings

Articles Related to Eastbourne Capital Management


Carl Icahn happy with Board Representation at Amylin Pharma

Date: February 10th, 2010
Shareholder activist investor Carl Icahn stated on January 25th that he will not seek additional representation on Amylin Pharmaceuticals, Inc.’s (NASDAQ:...

Icahn & Eastbourne Celebrate Disposal of Amylin's Chairman

Date: June 3rd, 2009
Last week it was announced that activist investors Carl Icahn and Eastbourne Capital Management had successfully elected Dr. Alexander J. Denner and Dr....

Shareholder Activist Week in Review

Date: June 1st, 2009
With proxy season in full throttle this past week, many of the most heated shareholder activist battles experienced major developments. The biggest activist...

Activist Hedge Funds Unite, P. Schoenfeld Supports Icahn and Eastbourne

Date: May 25th, 2009
Hedge fund manager P. Schoenfeld Asset Management (PSAM) announced that it will be voting in favor of the slate of board of directors for Amylin Pharmaceuticals...

Icahn Wants Amylin’s Chairman Ousted

Date: April 15th, 2009
In a letter today to Amylin Pharmaceuticals Chairman Joseph C. Cook, Jr., Carl Icahn expressed his frustration with the Mr. Cook’s performance and suggested...

Icahn Increases Stakes in Biotech Bets

Date: January 29th, 2009
SEC filings revealed today that Carl Icahn has increased his stakes in Amylin (AMLN) to 12.1 million shares (8.8%) and Enzon Pharmaceuticals (ENZN) to...

Return to Free Hedge Fund Investor Directory